Hikal launches pilot plant in Pune to boost pharma innovationIllustrative image – not actual.

Hikal has launched a new current Good Manufacturing Practice (cGMP) compliant pilot plant at its Research and Technology campus in Pune, strengthening its capabilities in pharmaceutical innovation and contract development and manufacturing (CDMO).

The facility is designed to help global pharmaceutical companies accelerate drug development by bridging the gap between laboratory research and commercial-scale production. It will support customers across the pharmaceutical lifecycle, including early-stage discovery, process development, clinical manufacturing, and commercial readiness. The new pilot plant features flexible and compliant infrastructure, including stainless steel and glass-lined reactors ranging from 20 to 2,000 litres, advanced distillation and filtration systems, and high-vacuum distillation units. The facility is equipped to handle complex processes such as cryogenic reactions and hydrogenation.

By enabling process development, technology transfer, and scalable production of active pharmaceutical ingredients (APIs) at one location, Hikal aims to reduce development timelines and improve operational efficiency for customers.

← All latest storiesBack to top →